The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial

P Panpan Zhang Z Zuoxing Niu H Hongqian Guo M Miao Zhang (State Key Laboratory of Advanced Materials for Intelligent Sensing, Key Laboratory of Organic Integrated Circuits, Ministry of Education & Tianjin Key Laboratory of Molecular Optoelectronic Sciences, Department of Chemistry, School of Science) S Shusuan Jiang (Hunan Cancer Hospital, Changsha, China) B Baoshan Cao C Chaohong He X Xinfang Hou J Jian Zhang J Jiajia Yuan Y Yujia Zhu Y Yingying Yu (Tempus AI, Inc.) C Caixia Sun P Peng Peng J Jean Fan J Jifang Gong J Jun Zhou L Lin Shen